Scientists track Body's inflammatory signals during immunotherapy
NCT ID NCT05707286
First seen Jan 07, 2026 · Last updated May 07, 2026 · Updated 24 times
Summary
This study looked at how the body's immune system reacts during cancer treatment with drugs called immune checkpoint inhibitors. Researchers measured inflammatory proteins in the blood of 98 adults with cancers like melanoma and lung cancer. The goal was to find patterns that could help doctors better manage side effects from these treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.